Company Description
biote Corp. operates in practice-building business within the hormone optimization space.
It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female.
The company was founded in 2012 and is headquartered in Irving, Texas.
| Country | United States |
| Founded | 2012 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 194 |
| CEO | Ms. Teresa S. Weber |
Contact Details
Address: 1875 W. Walnut Hill Ln #100 Irving, Texas 75038 United States | |
| Phone | 972-486-9346 |
| Website | biote.com |
Stock Details
| Ticker Symbol | BTMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819253 |
| CUSIP Number | 090683103 |
| ISIN Number | US0906831039 |
| Employer ID | 85-1791125 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Marc D. Beer | Executive Chairman |
| Teresa S. Weber | Chief Executive Officer and Director |
| Mary Elizabeth Conlon | Vice President of Business Development, General Counsel and Corporate Secretary |
| Robert Peterson | Chief Financial Officer |
| Joe Butler | Chief Information Officer |
| James Elliott Gibbs II | Chief People Officer |
| Richard Kevin Key | Chief Digital Officer |
| Jade Beutler | Head of Nutraceuticals |
| Dr. Ross W. McQuivey M.D. | Chief Medical Officer and Member of Medical Advisory Board |
| Dr. Cory Rice D.O. | Chief Clinical Advisor and Member of Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2024 | ARS | Filing |
| Apr 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 11, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 9, 2024 | 424B3 | Prospectus |
| Apr 9, 2024 | 424B3 | Prospectus |
| Apr 3, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Apr 2, 2024 | EFFECT | Notice of Effectiveness |
| Apr 2, 2024 | EFFECT | Notice of Effectiveness |
| Apr 1, 2024 | POS AM | Post-Effective amendments for registration statement |
| Apr 1, 2024 | POS AM | Post-Effective amendments for registration statement |